resources
 
 

PLEASE NOTE: When you access these resources, you are leaving the Elestrin website. Therefore, while these are respected medical organizations, Elestrin and Azur Pharma Inc. do not endorse the accuracy of the information you may find. We encourage you to talk to your doctor if you have questions about any of the information you find on these websites.

The following links are provided to assist you in finding additional information about menopause.

The American Medical Association (AMA) Essential Guide to Menopause

The National Institutes of Health (NIH)

The Mayo Clinic

The North American Menopause Society

American Congress of Obstetricians and Gynecologists

 

Important Safety InformationElestrin is indicated for the treatment of moderate-to-severe vasomotor symptoms associated with menopause.

Estrogens, with or without progestins, should not be used for the prevention of cardiovascular disease or dementia. Estrogen and progestin therapy has shown an increased risk of breast cancer, heart attack, and blood clots. Estrogen therapy, with or without progestins, increases the risk of stroke and dementia. Estrogen therapy alone increases the risk of endometrial cancer. The most frequently reported adverse events in clinical trials were nasopharyngitis, breast tenderness, upper respiratory tract infection, and metrorrhagia.

Please see Full Prescribing Information, including Black Box Warning

 
 

Close (x)

A Survey of 300 untreated menopausal women reveal what they want from the application of transdermal estrogen therapy†:

"I want a product I can apply and forget it."

"I’d rather just rub the product in and forget it’s there."

"For me, it’s easier to get into a daily habit."

"I like the control of applying [it] right on my upper arm."

"Make it clear and easy to apply."

†A blinded survey of 300 women with hot flashes to evaluate the importance of various attributes of transdermal estrogen therapy and the preference for various topical estrogen therapy products. Azur Pharma; 2009.